Parathyroid Disorders Market Size, Share, Trends, Insights and Global Industry Analysis By 2023

1. Parathyroid Disorders Market Size, Share, Trends, Insights and Global Industry Analysis By 2023 Market Highlights: It is estimated that the Parathyroid Disorders Market is expected to grow at a CAGR 6.5% during the forecast period of 2017-2023. Parathyroid hormone plays a significant role in regulating the metabolism of calcium, phosphate, and Vitamin D. The hyperparathyroidism, and hypoparathyroidism are the two most common parathyroid disorders. A number of factors such as growing geriatric population, rising prevalence of parathyroid disorders, increasing government assistance, rising healthcare expenditure, improving regulatory framework, and rising funding and reimbursements are propelling the growth of the global parathyroid disorders market. However, challenges in research and development, side-effects of treatment, the presence of misbranded and spurious drugs, expiration of patented drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market. Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/5451 Parathyroid Disorders Market Regional Analysis: The Americas dominate the global parathyroid disorders market owing to the rising prevalence of parathyroid disorders and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total healthcare expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%. Europe holds the second position in the parathyroid disorders market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of the European region. The Asia Pacific is the fastest growing parathyroid disorders market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total healthcare expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015. The Middle East & Africa holds the least market share due to lack of technical knowledge and poor medical facilities. Parathyroid Disorders Market Segmentation The global parathyroid disorders market is segmented on the basis of type, diagnosis, treatment, and end user.

2. On the basis of the type, the market is classified as hyperparathyroidism (HPT), parathyroid cancer, and hypoparathyroidism. The hyperparathyroidism is further sub-segmented into primary hyperparathyroidism, secondary hyperparathyroidism. hyperparathyroidism, and tertiary On the basis of the diagnosis, the market is classified as blood tests, imaging tests, and urine tests. The imaging tests is further sub-segmented into CT or CAT (computed axial tomography) scans, MRI (magnetic resonance imaging) scans, X-ray, ultrasound, bone density test, and sestamibi scan. On the basis of the treatment, the market is classified as surgery, radiation therapy, drugs, and others. The drugs segment is further sub-segmented into calcimimetics, hormone replacement therapy, and bisphosphonates. On the basis of the end user, the market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others. Parathyroid Disorders Market Key Players Some of the key players in the global parathyroid disorders market are Abbott Laboratories, Alcon Laboratories, Inc., Amgen Inc., Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly, Ethicon, Inc., Genentech, Medtronic, Merck, Mylan Laboratories, Novartis, Novo Nordisk, Pfizer, Roche, Smith & Nephew plc, Stryker, Teva Pharmaceutical Industries Ltd., Zimmer Biomet Holdings, Inc., and others. Table Of Contents: Chapter 1. Parathyroid Disorders MarketReport Prologue Chapter 2. Parathyroid Disorders MarketIntroduction 2.1 Definition 2.2 Scope Of The Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations Chapter 3.Parathyroid Disorders MarketResearch Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation

3. Chapter 4.Parathyroid Disorders Market Dynamics 4.1 Drivers 4.2 Restrains 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 4.6 Technology Trends & Assessment Chapter 5. Parathyroid Disorders Market Factor Analysis 5.1 Porter’s Five Forces Analysis 5.1.1 Bargaining Power Of Suppliers 5.1.2 Bargaining Power Of Buyers 5.1.3 Threat Of New Entrants 5.1.4 Threat Of Substitutes 5.1.5 Intensity Of Rivalry 5.2 Value Chain Analysis 5.3 Investment Feasibility Analysis 5.4 Pricing Analysis TOC Continued………… Brows More Details At: https://www.marketresearchfuture.com/reports/parathyroid-disorders-market- 5451 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

4. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com